In the April 15, 2024 issue of JAIDS Journal of Autoimmune Deficiency Syndromes, in the article by Erenrich et al1, “Effectiveness of PrEPTECH: Findings from a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention” mathematical errors have been published in Table 1. The percentage for Miami-Dade County has been corrected to 9.5% in the Region/Intervention cell and the percentage for San Francisco Bay has been corrected to 29.3% in the Region/Intervention cell. The published Table 1 also omits percentages from “prefer not to answer” responses. The data is not incorrect without these responses but the revised Table 1 below includes “prefer not to answer” responses for clarity.
TABLE 1.
Baseline Sociodemographic and Behavioral Characteristics Among Study Participants (Full Sample)
| Characteristics | All Participants (%, n = 229) | Intervention (%, n = 116) | Control (%, n = 113) | P |
| Age (yr), mean ± SD | 23.7 ± 2.8 | 23.6 ± 2.8 | 23.8 ± 2.8 | 0.427 |
| Highest level of schooling completed | 0.004 | |||
| Less than high school | 9 (3.9%) | 5 (4.3%) | 4 (3.5%) | |
| Graduated high school/GED | 25 (10.9%) | 14 (12.1%) | 11 (9.7%) | |
| Some college/technical school | 108 (47.2%) | 65 (56.0%) | 43 (38.1%) | |
| Bachelor's degree | 71 (31.0%) | 28 (24.1%) | 43 (38.1%) | |
| Graduate degree | 11 (4.8%) | 1 (0.9%) | 10 (8.8%) | |
| Prefer not to answer | 5 (2.2%) | 3 (2.6%) | 2 (1.8%) | |
| Gender identity | 0.484 | |||
| Cisgender male | 209 (91.3%) | 104 (89.7%) | 105 (92.9%) | |
| Transgender female | 20 (8.7%) | 12 (10.3%) | 8 (7.1%) | |
| Sexual orientation | 0.766 | |||
| Gay (or gay/queer) | 159 (69.4%) | 79 (68.1%) | 80 (70.8%) | |
| Bisexual (or bisexual/queer) | 44 (19.2%) | 24 (20.7%) | 20 (17.7%) | |
| Other | 24 (10.5%) | 11 (9.5%) | 13 (11.5%) | |
| Prefer not to answer | 2 (0.9%) | 2 (1.7%) | 0 (0.0%) | |
| Region | 0.373 | |||
| Broward county | 15 (6.6%) | 7 (6.0%) | 8 (7.1%) | |
| Miami-Dade county | 29 (12.7%) | 11 (9.5%) | 18 (15.9%) | |
| San Francisco Bay area | 59 (25.8%) | 34 (29.3%) | 25 (22.1%) | |
| Los Angeles county | 126 (55%) | 64 (55.2%) | 62 (54.9%) | |
| Race/ethnicity | 0.886 | |||
| White | 52 (22.7%) | 25 (21.6%) | 27 (23.9%) | |
| Black/African American | 15 (6.6%) | 9 (7.8%) | 6 (5.3%) | |
| Hispanic/Latinx | 85 (37.1%) | 43 (37.1%) | 42 (37.2%) | |
| Middle Eastern/North African | 3 (1.3%) | 1 (0.9%) | 2 (1.8%) | |
| Asian/Pacific Islander | 29 (12.7%) | 16 (13.8%) | 13 (11.5%) | |
| Multiracial | 43 (18.8%) | 21 (18.1%) | 22 (19.5%) | |
| American Indian/Alaska Native | 1 (0.4%) | 0 (0.0%) | 1 (0.9%) | |
| Prefer not to answer | 1 (0.4%) | 1 (0.9%) | 0 (0.0%) | |
| Language other than English spoken at home: | 131 (57.2%) | 68 (58.6%) | 63 (55.8%) | 0.690 |
| Health insurance status | 0.340 | |||
| Public insurance | 54 (23.6%) | 27 (23.3%) | 27 (23.9%) | |
| Private insurance through parent | 53 (23.1%) | 23 (19.8%) | 30 (26.5%) | |
| Other private insurance (through school, work, affordable care Act marketplace) | 63 (27.5%) | 29 (25.0%) | 34 (30.1%) | |
| Uninsured | 27 (11.8%) | 14 (12.1%) | 13 (11.5%) | |
| Other status | 20 (8.7%) | 14 (12.1%) | 6 (5.3%) | |
| Prefer not to answer | 12 (5.2%) | 9 (7.8%) | 3 (2.7%) | |
| Lives with parent or guardian | 95 (41.5%) | 50 (43.1%) | 45 (39.8%) | 0.420 |
| Previously took PrEP | 50 (21.8%) | 24 (20.7%) | 26 (23.0%) | 0.750 |
| No. of sex partners, lifetime, mean ± SD | 42 ± 107 | 54 ± 146 | 31 ± 39 | 0.121 |
| Diagnosed with an STI, past 6 mo | 198 (86.5%) | 99 (85.3%) | 99 (87.6%) | 0.701 |
REFERENCE
- 1.Erenrich RK, Braun RA, Torres-Mendoza DM, et al. Effectiveness of PrEPTECH: findings from a 180-day randomized controlled trial of a pre-exposure prophylaxis telehealth intervention. J Acquir Immune Defic Syndr. 2024;95:463–469. [DOI] [PMC free article] [PubMed] [Google Scholar]